chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Palpitations, Parosmia, Rhinorrhoea
Clinical narrative: slight pressure in left temple; some aches in the bones; light headedness for 2 days; brain fog; smelling a burnt smell/smelling burnt leaf smell; runny nose; fatigue for a couple of days; arm sore at left shoulder/left side muscle pain; axillary area sore for couple days; left lymph node sore for couple days; rapid heart rate/highest heart rate 110; half hour of chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (rapid heart rate/highest heart rate 110), HEAD DISCOMFORT (slight pressure in left temple), BONE PAIN (some aches in the bones), DIZZINESS (light headedness for 2 days) and CONFUSIONAL STATE (brain fog) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Long QT and Allergy. Concomitant products included LEVOTHYROXINE and VITAMIN D3 for an unknown indication.    On 04-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Sep-2021, the patient experienced PALPITATIONS (rapid heart rate/highest heart rate 110). On an unknown date, the patient experienced HEAD DISCOMFORT (slight pressure in left temple), BONE PAIN (some aches in the bones), DIZZINESS (light headedness for 2 days), CONFUSIONAL STATE (brain fog), PAROSMIA (smelling a burnt smell/smelling burnt leaf smell), RHINORRHOEA (runny nose), FATIGUE (fatigue for a couple of days), MYALGIA (arm sore at left shoulder/left side muscle pain), AXILLARY PAIN (axillary area sore for couple days), CHILLS (half hour of chills) and LYMPH NODE PAIN (left lymph node sore for couple days). At the time of the report, HEAD DISCOMFORT (slight pressure in left temple), BONE PAIN (some aches in the bones), DIZZINESS (light headedness for 2 days), CONFUSIONAL STATE (brain fog), PAROSMIA (smelling a burnt smell/smelling burnt leaf smell), RHINORRHOEA (runny nose), MYALGIA (arm sore at left shoulder/left side muscle pain), AXILLARY PAIN (axillary area sore for couple days), CHILLS (half hour of chills) and LYMPH NODE PAIN (left lymph node sore for couple days) had resolved and FATIGUE (fatigue for a couple of days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Sep-2021, Blood pressure measurement: normal (normal) Normal. On 04-Sep-2021, Heart rate: 110-100 (High) highest was 110and the lowest was 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. ?   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Non-Significant follow-up contain no new information
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: I tested positive for COVID-19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I tested positive for COVID-19 after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I tested positive for COVID-19 after vaccination). At the time of the report, COVID-19 (I tested positive for COVID-19 after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment medications were not provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects were minor; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects were minor) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects were minor). At the time of the report, VACCINATION COMPLICATION (side effects were minor) outcome was unknown.            The patient stated we were in our eighties. The problems we have were prior to the first shot.  Concomitant product use was not provided by the reporter. Treatment medication was not provided by the reporter.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided No treatment received by the patient
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Administered past the 30 day refrigeration time; Temperature changes (in F): 41-42; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time) and PRODUCT STORAGE ERROR (Temperature changes (in F): 41-42) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time) and PRODUCT STORAGE ERROR (Temperature changes (in F): 41-42). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time) and PRODUCT STORAGE ERROR (Temperature changes (in F): 41-42) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (administered past the 30 day refrigeration time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced PRODUCT STORAGE ERROR (administered past the 30 day refrigeration time). On 27-Aug-2021, PRODUCT STORAGE ERROR (administered past the 30 day refrigeration time) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant treatment was provided. No treatment medication was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swollen left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen left arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen left arm). At the time of the report, VACCINATION SITE SWELLING (Swollen left arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2021-315465 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, Erythema, Fatigue, Feeling abnormal
Clinical narrative: Next day, he felt awful; dizziness; anxiousness; fatigue; hot red spot the size of a silver dollar; arm was swollen and large/Next day, his arm felt the same; hot red spot the size of a silver dollar; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness), SKIN WARM (hot red spot the size of a silver dollar) and PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Sep-2021, the patient experienced SKIN WARM (hot red spot the size of a silver dollar), PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same) and ERYTHEMA (hot red spot the size of a silver dollar). On 09-Sep-2021, the patient experienced FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness) and FATIGUE (fatigue). At the time of the report, FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness), SKIN WARM (hot red spot the size of a silver dollar), PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same), ERYTHEMA (hot red spot the size of a silver dollar) and FATIGUE (fatigue) was resolving.            No concomitant medications were reported. No treatment medications were reported.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Skin warm
Clinical narrative: Next day, he felt awful; dizziness; anxiousness; fatigue; hot red spot the size of a silver dollar; arm was swollen and large/Next day, his arm felt the same; hot red spot the size of a silver dollar; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness), SKIN WARM (hot red spot the size of a silver dollar) and PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Sep-2021, the patient experienced SKIN WARM (hot red spot the size of a silver dollar), PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same) and ERYTHEMA (hot red spot the size of a silver dollar). On 09-Sep-2021, the patient experienced FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness) and FATIGUE (fatigue). At the time of the report, FEELING ABNORMAL (Next day, he felt awful), DIZZINESS (dizziness), ANXIETY (anxiousness), SKIN WARM (hot red spot the size of a silver dollar), PERIPHERAL SWELLING (arm was swollen and large/Next day, his arm felt the same), ERYTHEMA (hot red spot the size of a silver dollar) and FATIGUE (fatigue) was resolving.            No concomitant medications were reported. No treatment medications were reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache
Clinical narrative: Difficult to breathing; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficult to breathing), CHILLS (Chills) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, the patient experienced DYSPNOEA (Difficult to breathing), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Difficult to breathing), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            No concomitant medication reported. No treatment information was provided
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Expired product administered, Fatigue, Product administration error, Product storage error
Clinical narrative: 101.6 degrees fever; Post vaccine fatigue; product storage error; product administration error; Expired dose administered to patient/Expired vaccine dose; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (101.6 degrees fever), FATIGUE (Post vaccine fatigue), EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose), PRODUCT STORAGE ERROR (product storage error) and PRODUCT ADMINISTRATION ERROR (product administration error) in a 98-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002S21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 08-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose) and PRODUCT ADMINISTRATION ERROR (product administration error). On an unknown date, the patient experienced PYREXIA (101.6 degrees fever), FATIGUE (Post vaccine fatigue) and PRODUCT STORAGE ERROR (product storage error). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 08-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose) and PRODUCT ADMINISTRATION ERROR (product administration error) had resolved. At the time of the report, PYREXIA (101.6 degrees fever) and FATIGUE (Post vaccine fatigue) outcome was unknown and PRODUCT STORAGE ERROR (product storage error) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.6 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. The reporter states that the patient received expired vaccine. vial that was opened on 01 September 2021 from the refrigerator was used that put back in refrigerator and took back out of refrigerator on 08 Sep 2021 and reporter states patient had an immune response due to fever 101.6 degrees fever and post vaccine fatigue
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 101.6 degrees fever; Post vaccine fatigue; product storage error; product administration error; Expired dose administered to patient/Expired vaccine dose; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (101.6 degrees fever), FATIGUE (Post vaccine fatigue), EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose), PRODUCT STORAGE ERROR (product storage error) and PRODUCT ADMINISTRATION ERROR (product administration error) in a 98-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002S21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 08-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose) and PRODUCT ADMINISTRATION ERROR (product administration error). On an unknown date, the patient experienced PYREXIA (101.6 degrees fever), FATIGUE (Post vaccine fatigue) and PRODUCT STORAGE ERROR (product storage error). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 08-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient/Expired vaccine dose) and PRODUCT ADMINISTRATION ERROR (product administration error) had resolved. At the time of the report, PYREXIA (101.6 degrees fever) and FATIGUE (Post vaccine fatigue) outcome was unknown and PRODUCT STORAGE ERROR (product storage error) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.6 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. The reporter states that the patient received expired vaccine. vial that was opened on 01 September 2021 from the refrigerator was used that put back in refrigerator and took back out of refrigerator on 08 Sep 2021 and reporter states patient had an immune response due to fever 101.6 degrees fever and post vaccine fatigue
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Little itching on the injection arm; Little swelling on the injection arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Little swelling on the injection arm) and VACCINATION SITE PRURITUS (Little itching on the injection arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced VACCINATION SITE SWELLING (Little swelling on the injection arm) and VACCINATION SITE PRURITUS (Little itching on the injection arm). At the time of the report, VACCINATION SITE SWELLING (Little swelling on the injection arm) and VACCINATION SITE PRURITUS (Little itching on the injection arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-315671 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Fatigue, Myalgia, Vitreous floaters
Clinical narrative: losing my hair a lot/ hair is falling out/ huge bald spot; body aches; tired; sore arm; tracers in my eyes/see water squigglies in the air; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (tracers in my eyes/see water squigglies in the air), ALOPECIA (losing my hair a lot/ hair is falling out/ huge bald spot), MYALGIA (sore arm), MYALGIA (body aches) and FATIGUE (tired) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2021, the patient experienced VITREOUS FLOATERS (tracers in my eyes/see water squigglies in the air) and MYALGIA (sore arm). On 19-Aug-2021, the patient experienced MYALGIA (body aches) and FATIGUE (tired). On an unknown date, the patient experienced ALOPECIA (losing my hair a lot/ hair is falling out/ huge bald spot). At the time of the report, VITREOUS FLOATERS (tracers in my eyes/see water squigglies in the air), ALOPECIA (losing my hair a lot/ hair is falling out/ huge bald spot), MYALGIA (sore arm), MYALGIA (body aches) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching on the injection arm but it is more than first dose; Swelling on the injection arm but it is more than with the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose). At the time of the report, VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose) had not resolved.            No Concomitant medication details were provided.   No Treatment medication details were provided.   This case was linked to MOD-2021-315645 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchiness; Big red well; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Big red well) and VACCINATION SITE SWELLING (Swelling) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012E21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy and Drug allergy. Concomitant products included MULTIVITAMINS [VITAMINS NOS] and LISINOPRIL for an unknown indication.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Big red well) and VACCINATION SITE SWELLING (Swelling). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Big red well) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Incidence of fever they day after/have a fever of 100.4; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Incidence of fever they day after/have a fever of 100.4) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Incidence of fever they day after/have a fever of 100.4). At the time of the report, PYREXIA (Incidence of fever they day after/have a fever of 100.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.4 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Is diarrhea a side effect?; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Is diarrhea a side effect?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Is diarrhea a side effect?). At the time of the report, DIARRHOEA (Is diarrhea a side effect?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Erythema, Headache, Herpes zoster, Pain in extremity
Clinical narrative: Itchy; Redness; Sore arm; Headache; Shingles between his ear and temple, down to the back of his neck; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck), PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck), PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck) had resolved and PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, COVID-19: negative (Negative) Negative.         No treatment information was provided  Prior to the vaccine around last holiday season, patient  has been getting lots of headache and blurred vision. Several tests were done and doctors then found out that he had a condition that could cause blindness if not treated. That is why he was prescribed with Prednisone.   This case was linked to MOD-2021-318230 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Sep-2021: Follow-up information received on 12-SEP-2021 and contains non-significant information
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy; Redness; Sore arm; Headache; Shingles between his ear and temple, down to the back of his neck; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck), PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck), PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, HERPES ZOSTER (Shingles between his ear and temple, down to the back of his neck) had resolved and PRURITUS (Itchy), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, COVID-19: negative (Negative) Negative.         No treatment information was provided  Prior to the vaccine around last holiday season, patient  has been getting lots of headache and blurred vision. Several tests were done and doctors then found out that he had a condition that could cause blindness if not treated. That is why he was prescribed with Prednisone.   This case was linked to MOD-2021-318230 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Sep-2021: Follow-up information received on 12-SEP-2021 and contains non-significant information
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PAIN (Pain at injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product reported by reporter. No treatment medication reported by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered past the 30 day refrigeration time; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 06-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported  No treatment information provided by the reporter
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Nausea, Off label use
Clinical narrative: Big knot at injection site; Weakness; Shooting pain inside her head; Chills; Nausea; Extra dose administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big knot at injection site), ASTHENIA (Weakness), OFF LABEL USE (Extra dose administered), HEADACHE (Shooting pain inside her head) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced OFF LABEL USE (Extra dose administered). On 10-Sep-2021, the patient experienced VACCINATION SITE MASS (Big knot at injection site), ASTHENIA (Weakness), HEADACHE (Shooting pain inside her head), CHILLS (Chills) and NAUSEA (Nausea). On 09-Sep-2021, OFF LABEL USE (Extra dose administered) outcome was unknown. On 11-Sep-2021, HEADACHE (Shooting pain inside her head), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE MASS (Big knot at injection site) and ASTHENIA (Weakness) had not resolved.            No concomitant medication reported. No treatment medication reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Big knot at injection site; Weakness; Shooting pain inside her head; Chills; Nausea; Extra dose administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big knot at injection site), ASTHENIA (Weakness), OFF LABEL USE (Extra dose administered), HEADACHE (Shooting pain inside her head) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced OFF LABEL USE (Extra dose administered). On 10-Sep-2021, the patient experienced VACCINATION SITE MASS (Big knot at injection site), ASTHENIA (Weakness), HEADACHE (Shooting pain inside her head), CHILLS (Chills) and NAUSEA (Nausea). On 09-Sep-2021, OFF LABEL USE (Extra dose administered) outcome was unknown. On 11-Sep-2021, HEADACHE (Shooting pain inside her head), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE MASS (Big knot at injection site) and ASTHENIA (Weakness) had not resolved.            No concomitant medication reported. No treatment medication reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effect). At the time of the report, VACCINATION COMPLICATION (Side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information provided by the reporter. No treatment information provided .
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Fatigue, Heart rate irregular
Clinical narrative: the blood pressure goes high and low al day long; the pulse and the blood presure goes high and low all day along; some fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (the blood pressure goes high and low al day long), HEART RATE IRREGULAR (the pulse and the blood presure goes high and low all day along) and FATIGUE (some fatigue) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE FLUCTUATION (the blood pressure goes high and low al day long), HEART RATE IRREGULAR (the pulse and the blood presure goes high and low all day along) and FATIGUE (some fatigue). At the time of the report, BLOOD PRESSURE FLUCTUATION (the blood pressure goes high and low al day long), HEART RATE IRREGULAR (the pulse and the blood presure goes high and low all day along) and FATIGUE (some fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was reported.  Patient reported- No pain no discomfort no breathing issues.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough). At the time of the report, COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had been exposed to the virus.  No Concomitant medications were reported.  No Treatment information was reported..   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose on 5 Aug 2021, second dose on 10 Sept 2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 5 Aug 2021, second dose on 10 Sept 2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy (Every two weeks) since an unknown date.   On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 5 Aug 2021, second dose on 10 Sept 2021). On 10-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 5 Aug 2021, second dose on 10 Sept 2021) had resolved.            No Concomitant medication was reported. No treatment medications were reported.   This case was linked to MOD-2021-318336 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Fibromyalgia
Clinical narrative: fibromyalgia; joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FIBROMYALGIA (fibromyalgia) and ARTHRALGIA (joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FIBROMYALGIA (fibromyalgia) and ARTHRALGIA (joint pain). At the time of the report, FIBROMYALGIA (fibromyalgia) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: F
Vaccine: FLU3
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: Pregnant patient received fluzone, no AE; Initial information received on 09-Sep-2021 regarding an unsolicited valid non-serious case from an other health professional and physician.  This case involves pregnant female patient (unknown age) who was exposed to INFLUENZA VACCINE TRIVALENT (FLUZONE). Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported event occurred at unknown gestation period (exposure during pregnancy).  The date of last menstrual period was reported as 08-May-2021.  The estimated delivery due date was 17-Feb-2022.  The information on patient's previous pregnancy was unknown.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  It was unknown if the patient received concomitant medication.  The patient's past medical treatment(s), vaccination(s), and family history were not provided.  On an unknown date, the patient received a dose of suspect FLUZONE (one dosage form, lot 477325SA and expiration date: 30-Jun-2022) via intramuscular route in an unknown administration site for prophylactic vaccination.  It was a case of vaccine exposure during pregnancy (same day latency).  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were laboratory data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, no adverse event was reported and the outcome was unknown for the reported event.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Fatigue, Hyperhidrosis, Lymph node pain
Clinical narrative: I felt fine throughout the day? just a little arm soreness until about 9pm, I felt extremely tired. I went to bed and woke up at 11:53pm with excruciating right arm / Axilla pain . Then the chills set in, I woke up at 5AM with profuse sweating., neck and back stiffness. That morning I noticed my axilla is largely swollen and very sore to touch. Today, continued axilla swelling and very sore arm.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: I felt fine throughout the day? just a little arm soreness until about 9pm, I felt extremely tired. I went to bed and woke up at 11:53pm with excruciating right arm / Axilla pain . Then the chills set in, I woke up at 5AM with profuse sweating., neck and back stiffness. That morning I noticed my axilla is largely swollen and very sore to touch. Today, continued axilla swelling and very sore arm.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Neck pain, Pain, Pain in extremity
Clinical narrative: 1 week after the shot, symptoms are worse with the pain in left arm & neck & back. Also have pain behind my left knee. Still experiencing radiating pain from the area where the shot was received. Been using heat/ice/tylonel.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swollen Neck, ever since then my neck will still get swollen but then goes down.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Emotional distress, Heavy menstrual bleeding, Menstrual disorder, Pain
Clinical narrative: Menstrual cycle changes: increased pain and duration of cramps, heavier flow, increased emotional/cognitive stress. I received the vaccine in July and my periods in July, August, and September have all been more difficult than before the vaccine.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Stress
Clinical narrative: Menstrual cycle changes: increased pain and duration of cramps, heavier flow, increased emotional/cognitive stress. I received the vaccine in July and my periods in July, August, and September have all been more difficult than before the vaccine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Laboratory test normal
Clinical narrative: I no longer have my period.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Fatigue, Injection site erythema, Injection site swelling
Clinical narrative: Teeth-chattering chills (around 30 minutes duration), fever,  nausea and vomiting, tired, bruising, swelling and redness at the injection site.  The bruising, redness and swelling is still present today (9-20).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Teeth-chattering chills (around 30 minutes duration), fever,  nausea and vomiting, tired, bruising, swelling and redness at the injection site.  The bruising, redness and swelling is still present today (9-20).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Booster Given Too Early-
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blindness, Flushing, Hyperhidrosis, Paraesthesia
Clinical narrative: Systemic: eyesight was going out. blurred vision-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: after receive shot pt started to have blurred vision, tingling sweating, back pain. the vision wasnt coming back so we called the ambulance. she started to feel better. they check her vitals, everything fine. maybe having a panic attack
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Visual impairment
Clinical narrative: Systemic: eyesight was going out. blurred vision-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: after receive shot pt started to have blurred vision, tingling sweating, back pain. the vision wasnt coming back so we called the ambulance. she started to feel better. they check her vitals, everything fine. maybe having a panic attack